source Post navigation Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight – Eli Lilly and Company One-third of Kentuckians are prediabetic, this simple quiz can help you determine your risk – Northern Kentucky Tribune
